TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/11/26 08:45 | 2/10/26 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Germano Geno J | L3 | D | P | 30 | 1.49 | 0 | 20 | 0 | D | ||||||||||||||||
12/17/25 07:02 | 12/16/25 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Germano Geno J | NC | D | P | 14 | 4.72 | 0 | 3 | 14 | 24 | D | |||||||||||||||
6/4/25 17:01 | 5/27/25 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Germano Geno J | NC | D | M.d | 0 | 0.00 | 0 | 10 | 89 | 21 | D | |||||||||||||||
3/27/25 07:00 | 3/25/25 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Germano Geno J | NC | D | P | 17 | 5.30 | 0 | 3 | 42 | 11 | D | |||||||||||||||
1/2/25 07:00 | 12/30/24 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Germano Geno J | NC | D | P | 16 | 4.49 | 0 | 4 | 86 | 8 | D | |||||||||||||||
5/7/24 16:25 | 5/4/24 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Germano Geno J | NC | D | M.d | 0 | 0.00 | 0 | 4 | New | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |